Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 97-108 of 1,909
Drug study icon
CompletedNCT00195845

A Study of Galantamine to Improve Cognitive Dysfunction in Bipolarity

This study is completed in the United States. It is testing galantamine to Improve Cognitive Dysfunction for Bipolarity.

In Cambridge
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Cambridge Health Alliance
Condition
Bipolarity
Drug study icon
WithdrawnNCT00512616

A Glutamate Transporter GLT1, in the Treatment of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity
Drug study icon
CompletedNCT00606229

Safety and Efficacy of Long-term Administration of Aripiprazole for Bipolarity

This study is completed in Japan. It is testing Safety and Efficacy of Long-term Administration of Aripiprazole for Bipolarity.

Multiple locations, including Chugoku Region
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity
Drug study icon
CompletedNCT00606320

Safety and Efficacy of Extended Administration of Aripiprazole for Bipolarity

This study is completed in China, in Japan, in South Korea, .... It is testing safety and Efficacy of Extended Administration of Aripiprazole for Bipolarity.

Multiple locations, including Hong Kong
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
China, Japan, South Korea, ...
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity
Drug study icon
CompletedNCT00606177

A Investigative Extension study of the Safety and Efficacy of Aripiprazole in the Treatment of people with Bipolarity Experiencing a Manic or Mixed Episode

This study is completed in China, in Japan, in South Korea, .... It focuses on Bipolarity.

Multiple locations, including Hong Kong
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
China, Japan, South Korea, ...
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity
Behavioral study icon
TerminatedNCT02446509

A Psychoeducation Intervention for Caregivers of people with Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralOver 18 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity
Other study type icon
CompletedNCT03017781

The Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolarity

This study is completed in the United States. It is testing relationship of Psychosocial Function With Mood Symptoms for Bipolarity.

Multiple locations, including Culver City
Why is this study shown?

This study is directly about Bipolarity.

BipolarityObservationalA study where researchers collect information without assigning a treatment.From 15 Years to 25 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Bipolarity
Drug study icon
CompletedNCT00490971

Effectiveness of Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Bipolarity

This study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.

Multiple locations, including Scottsdale
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
Drug study icon
CompletedNCT00309699

Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity

This study is completed in the United States, in Greece, in Lithuania, .... It is testing Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Greece, Lithuania, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.